Skip to main content
TipRanks
Go Ultimate75% OFF

Medican Enterprises (MDCN) Ratios

48 Followers

Medican Enterprises Ratios

MDCN's free cash flow for Q3 2022 was $4.46M. For the 2022 fiscal year, MDCN's free cash flow was increased by $0.00 and operating cash flow was $4.46M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio0.000.000.000.00
Quick Ratio0.000.000.000.00
Cash Ratio0.000.000.000.00
Solvency Ratio0.350.040.170.01
Operating Cash Flow Ratio0.000.000.000.00
Short-Term Operating Cash Flow Coverage0.000.000.000.00
Net Current Asset Value$ -19.74M$ -25.07M$ -27.85M$ -34.43M
Leverage Ratios
Debt-to-Assets Ratio0.410.580.690.84
Debt-to-Equity Ratio0.701.412.215.10
Debt-to-Capital Ratio0.410.580.690.84
Long-Term Debt-to-Capital Ratio0.410.580.690.84
Financial Leverage Ratio1.702.413.216.10
Debt Service Coverage Ratio84.754.319.576.88
Interest Coverage Ratio8.861.55-0.183.39
Debt to Market Cap5088.663264.3627618.8634123.26
Interest Debt Per Share0.000.000.000.00
Net Debt to EBITDA2.7921.105.41101.08
Profitability Margins
Gross Profit Margin48.29%47.89%19.38%100.00%
EBIT Margin246.68%10.10%397.10%26.91%
EBITDA Margin270.83%28.03%465.94%54.58%
Operating Profit Margin28.31%10.10%-8.81%26.91%
Pretax Profit Margin243.46%3.60%348.46%18.98%
Net Profit Margin243.46%3.60%348.46%18.98%
Continuous Operations Profit Margin243.46%3.60%348.46%18.98%
Net Income Per EBT100.00%100.00%100.00%100.00%
EBT Per EBIT859.93%35.65%-3955.78%70.52%
Return on Assets (ROA)13.17%0.35%9.50%0.29%
Return on Equity (ROE)22.35%0.84%30.52%1.75%
Return on Capital Employed (ROCE)1.53%0.98%-0.24%0.41%
Return on Invested Capital (ROIC)1.53%0.98%-0.24%0.41%
Return on Tangible Assets13.17%0.35%9.50%0.29%
Earnings Yield163101.91%1959.85%381150.31%11732.83%
Efficiency Ratios
Receivables Turnover0.000.000.000.00
Payables Turnover0.000.000.000.00
Inventory Turnover0.000.000.000.00
Fixed Asset Turnover0.120.240.070.07
Asset Turnover0.050.100.030.02
Working Capital Turnover Ratio11.9922.0355.200.00
Cash Conversion Cycle0.000.000.000.00
Days of Sales Outstanding0.000.000.000.00
Days of Inventory Outstanding0.000.000.000.00
Days of Payables Outstanding0.000.000.000.00
Operating Cycle0.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share0.000.000.000.00
Free Cash Flow Per Share0.000.000.000.00
Dividend Paid and CapEx Coverage Ratio1493319.00303436.500.000.00
Capital Expenditure Coverage Ratio1493319.00303436.500.000.00
Operating Cash Flow Coverage Ratio0.300.050.490.01
Operating Cash Flow to Sales Ratio2.290.2912.420.47
Free Cash Flow Yield153377.42%15582.83%1358843.16%28839.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio0.000.050.000.01
Price-to-Sales (P/S) Ratio0.000.000.000.00
Price-to-Book (P/B) Ratio0.000.000.000.00
Price-to-Free Cash Flow (P/FCF) Ratio0.000.010.000.00
Price-to-Operating Cash Flow Ratio0.000.010.000.00
Price-to-Earnings Growth (PEG) Ratio0.00-0.000.000.00
Enterprise Value Multiple2.7921.115.41101.08
Enterprise Value19.75M25.07M27.85M34.43M
EV to EBITDA2.7921.115.41101.08
EV to Sales7.575.9225.2355.17
EV to Free Cash Flow3.3120.662.03118.27
EV to Operating Cash Flow3.3120.662.03118.27
Tangible Book Value Per Share0.000.000.000.00
Shareholders’ Equity Per Share0.000.000.000.00
Tax and Other Ratios
Effective Tax Rate0.000.000.000.00
Revenue Per Share0.000.000.000.00
Net Income Per Share0.000.000.000.00
Tax Burden1.001.001.001.00
Interest Burden0.990.360.880.71
Research & Development to Revenue0.000.000.000.00
SG&A to Revenue0.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.00
Income Quality0.947.953.572.46

Currency in USD